Risperidone Kit
Product Images NDC 0480-1232

Product Visual Gallery

This gallery contains 53 technical images submitted to the FDA as part of the official labeling for Risperidone (NDC 0480-1232). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Diagram showing components of the Risperidone injection kit by Teva Pharmaceuticals, Inc. It includes labeled illustrations of the vial adapter with luer tip connector and spike tip, a prefilled syringe with diluent, plunger rod, white collar, and cap, a vial containing microspheres with a colored cap, and Terumo SurGuard 3 injection needles labeled for deltoid (1-inch) and gluteal (2-inch) use with transparent needle protectors and needle safety devices.*

FDA Label Image

1 (Image 10)

An instructional illustration showing a hand holding a pen-like medical device horizontally, with an 'Incorrect' label indicating improper usage of the device. The image is likely part of a kit for Risperidone, provided by Teva Pharmaceuticals, Inc., demonstrating how not to hold the product during use.*

FDA Label Image

1 (Image 11)

Illustration showing a risperidone syringe after the cap has been removed. The image highlights the appearance of the syringe ready for use, with a clear barrel and plunger visible, emphasizing the condition of the kit component upon opening.*

FDA Label Image

1 (Image 12)

Illustration showing hands demonstrating how to use a syringe vial adapter. One hand holds a vial, while the other pushes the syringe down onto the vial's top, guided by a downward arrow indicating the motion.*

FDA Label Image

1 (Image 13)

Instructional illustration showing a hand holding a risperidone kit component, demonstrating the motion of pressing and pulling the pump for 10 seconds to prepare the medication.*

FDA Label Image

1 (Image 14)

An instructional diagram showing a hand holding a vial upside down and drawing liquid into a syringe below it, with a downward arrow indicating the direction of fluid transfer. This likely demonstrates how to prepare a medication dose from a vial using a syringe.*

FDA Label Image

1 (Image 15)

An instructional illustration showing a hand holding a dropper-style container of Risperidone, dispensing liquid into an oral syringe held by the other hand. Arrows indicate the steps for transferring the medication from the bottle to the syringe, demonstrating proper use of the Risperidone oral dosing kit.*

FDA Label Image

1 (Image 16)

Instruction panel indicating that vial contents will be under pressure and advising the user to keep holding the plunger rod down with the thumb. This is part of the usage instructions for a kit, possibly for Risperidone by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 17)

Instructional diagram illustrating injection sites and needle lengths for Risperidone kit. The left panel shows a deltoid injection site on an upper arm with a 1-inch needle, while the right panel depicts a gluteal injection site on the buttock with a 2-inch needle. Each site is indicated by a shaded body area and corresponding needle length visual.*

FDA Label Image

1 (Image 18)

An instructional illustration showing a person removing or peeling back a protective film from a swab or test strip, demonstrating the step to prepare the device for use in a kit format. An arrow indicates the direction of peeling the film.*

FDA Label Image

1 (Image 19)

An instructional illustration showing a hand gripping a device and moving it up and down along a vertical tube or extension, indicating a motion or method of use. The image is likely part of the Risperidone kit instructions from Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 2)

An instructional illustration showing a rectangular box below a clock icon indicating 30 minutes. This suggests a time-related step or wait period associated with the product kit.*

FDA Label Image

1 (Image 20)

An instructional illustration showing a person manipulating a cap component of a device. It depicts the cap being lifted upward and then pulled off, demonstrating the removal process from the main device, likely part of the Risperidone kit by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 21)

An instructional line drawing showing hands assembling a syringe with a vial. One hand holds the syringe barrel with a vial attached, while the other hand pulls the plunger downward as indicated by an upward pointing arrow, demonstrating the drawing of liquid into the syringe.*

FDA Label Image

1 (Image 22)

An instructional diagram showing a human figure from the back with arrows indicating two injection sites: the upper arm (deltoid area) and the buttock (gluteal area). This illustration likely relates to administration guidance for the Risperidone kit.*

FDA Label Image

1 (Image 23)

An instructional diagram demonstrating how to use a tool, likely a kit component. It shows a hand holding a device that is aligned with an object, followed by an insert depicting the tool's tip after use, indicated by the word "AFTER." An arrow points downwards, suggesting a motion or application step involved.*

FDA Label Image

1 (Image 24)

An illustration showing a hand depositing a syringe into a medical sharps disposal container with a biohazard symbol on the front. The container has a flip-top lid designed to safely receive and contain used sharps.*

FDA Label Image

1 (Image 25)

Chemical structure of Risperidone, the active ingredient, showing its molecular framework with characteristic rings and functional groups.*

FDA Label Image

1 (Image 26)

Illustrated components of the Risperidone injection kit from Teva Pharmaceuticals, Inc. including a vial adapter with labeled parts (Luer tip connector, spike tip, skirt), a prefilled syringe showing the plunger rod, diluent, white collar, and white cap, a vial with microspheres and colored cap, and two Terumo SurGuard 3 injection needles labeled for deltoid (1-inch) and gluteal (2-inch) use with transparent needle protectors and needle safety devices.*

FDA Label Image

1 (Image 27)

An illustration showing a rectangular box with an adjacent circular timer graphic indicating 30 minutes. This likely represents a timing or waiting instruction related to the Risperidone kit by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 28)

An instructional illustration showing hands removing the cap from a vial, demonstrating the correct way to open it. This image is related to the Risperidone prescription drug kit by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 29)

An instructional illustration showing hands opening or handling a Risperidone kit component, possibly demonstrating preparation or administration steps for the medication. The image is a line drawing focused on hand positioning and kit parts.*

FDA Label Image

1 (Image 3)

An instructional illustration showing a hand removing the cap from a vial, likely part of the Risperidone kit by Teva Pharmaceuticals, Inc. The image demonstrates how to open the vial prior to use.*

FDA Label Image

1 (Image 30)

An instructional illustration showing hands preparing a medication kit. The image depicts one hand holding a vial and the other hand inserting a cap or stopper into the vial, with a downward arrow indicating the direction of placement. This is related to the Risperidone human prescription drug kit by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 31)

An instructional illustration showing a hand holding a vial with a rubber stopper and a cap, demonstrating a step likely related to medication preparation or administration from a kit format. The image focuses on the proper handling or opening of the vial.*

FDA Label Image

1 (Image 32)

Illustration showing a hand holding a small capped object, likely a vial or container, with the thumb and fingers. The image is a black and white line drawing. No text or labels are visible.*

FDA Label Image

1 (Image 33)

An instructional illustration showing two hands snapping off the top of a tablet or capsule, accompanied by the text "SNAP!" indicating the action to break or open the dosage form, related to a Risperidone kit by Teva Pharmaceuticals.*

FDA Label Image

1 (Image 34)

An instructional illustration showing the preparation of a medicine vial with a syringe. It depicts a hand inserting a syringe into the vial stopper and an arrow indicating downward pressure, with another arrow showing a twisting motion to properly attach or detach the syringe. The image is part of a kit for administering Risperidone by Teva Pharmaceuticals.*

FDA Label Image

1 (Image 35)

An illustration showing a hand holding a pen-like device horizontally with the label "Incorrect" indicating that this is an improper way to hold or use the device. The device appears to have a cap on one end.*

FDA Label Image

1 (Image 36)

An instructional illustration showing a syringe with the cap removed. The syringe is partially filled and labeled to explain that this is what the syringe looks like once the cap is taken off, as part of the Risperidone kit by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 37)

An instructional illustration showing two hands preparing a medication injection: one hand holds a vial steady, while the other inserts a syringe needle into the vial, with a downward-pointing arrow indicating the injection direction. This image is associated with Risperidone medication kit preparation by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 38)

An instructional diagram showing hands holding a Risperidone kit component, demonstrating a pressing and pulling motion with an arrow indicating the direction. A timer icon indicates a 10-second wait period as part of the preparation or administration process.*

FDA Label Image

1 (Image 39)

An instructional illustration showing a hand holding a vial upside down and drawing liquid into a syringe. A downward arrow indicates the direction of the action. The image is part of a risperidone kit provided by Teva Pharmaceuticals, Inc., demonstrating proper use of the included vial and syringe for medication preparation.*

FDA Label Image

1 (Image 4)

An instructional illustration showing two hands preparing a medication dose using a small vial, likely as part of a Risperidone kit. One hand holds the vial while the other hand manipulates a cap or stopper, demonstrating a step in medication preparation or administration.*

FDA Label Image

1 (Image 40)

An instructional diagram showing a hand holding a tube with the cap being removed and the contents being squeezed out onto an applicator or device held in the other hand. The diagram includes an arrow indicating the direction to twist or remove the cap.*

FDA Label Image

1 (Image 41)

Instructional label advising that the vial contents will be under pressure and to keep holding the plunger rod down with the thumb. This is part of a kit for Risperidone by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 42)

An instructional diagram illustrating injection sites and needle lengths. The left panel shows the deltoid muscle injection site with a 1-inch needle, and the right panel shows the gluteal muscle injection site with a 2-inch needle. Both sections include simplified human figures and corresponding syringe illustrations.*

FDA Label Image

1 (Image 43)

An instructional illustration showing hands opening a test cassette or similar device. The image includes a circular arrow indicating to lift or peel off a covering tab from the cassette before use, likely as part of a testing or diagnostic kit procedure.*

FDA Label Image

1 (Image 44)

An instructional illustration showing a hand gripping and pulling on a device, with arrows indicating an up-and-down motion. This appears to depict a step in the use or preparation of a medication kit.*

FDA Label Image

1 (Image 45)

An instructional illustration showing hands operating a device, possibly preparing or loading a component by bending or snapping a piece as indicated by directional arrows. The image is black and white line art focusing on the hand movements and device interaction, likely part of the user instructions for Risperidone kit by Teva Pharmaceuticals.*

FDA Label Image

1 (Image 46)

An instructional illustration showing a hand holding a syringe with an extended plunger, and a bottle connected to the syringe's top. Another hand is positioned to pull the plunger upward, indicated by an upward arrow, demonstrating how to draw liquid from the vial into the syringe. The image is part of a kit for the prescription drug Risperidone by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 47)

An anatomical illustration showing the back view of a human body. Two arrows indicate injection sites: one on the upper arm and one on the buttock area, used for guidance in administration.*

FDA Label Image

1 (Image 48)

An instructional illustration showing the use of a kit component. It depicts a hand cutting or opening a section of the kit, followed by an inset circle showing a close-up of the correct application or use labeled 'AFTER.' The image guides on preparation or administration using the kit.*

FDA Label Image

1 (Image 49)

An instructional illustration showing a hand holding a pair of tweezers above a container with a biohazard symbol, suggesting the disposal of a medical testing or diagnostic component. The container has a secure lid and a slot for depositing items.*

FDA Label Image

1 (Image 5)

An instructional diagram showing two hands preparing a medication vial and a syringe. One hand holds a vial upright while the other inserts a syringe needle into the vial, indicated by a downward arrow. This image is part of a kit, likely demonstrating proper medication preparation technique.*

FDA Label Image

Carton 12.5 mg/vial (Image 50)

Packaging label for RisperiDONE for Extended-Release Injectable Suspension 12.5 mg/vial Single-Dose Pack by Teva Pharmaceuticals, Inc. This kit includes a single 12.5 mg vial, a pre-filled syringe with 2 mL diluent, a vial adapter, and two safety needles for deltoid and gluteal injection. The label instructs refrigerated storage and specifies administration by a healthcare professional.*

FDA Label Image

Carton 25 mg/vial (Image 51)

Packaging label for Risperidone extended-release injectable suspension, 25 mg per vial, in a single-dose kit by Teva Pharmaceuticals. The kit includes one vial with microspheres for injection, one prefilled syringe with diluent, one vial adapter, and safety needles for deltoid and gluteal injections. The label instructs storage in a refrigerator and highlights administration by a healthcare professional.*

FDA Label Image

Carton 37.5 mg/vial (Image 52)

Packaging label for Risperidone Extended-Release Injectable Suspension 37.5 mg per vial single-dose pack by Teva Pharmaceuticals. The kit includes one vial of risperidone extended-release microspheres for injection, a pre-filled syringe with diluent, vial adapter, and safety needles for deltoid and gluteal intramuscular injections. Label instructs to store the package in a refrigerator and highlights single-dose use for healthcare professional administration only.*

FDA Label Image

Carton 50 mg/vial (Image 53)

Box packaging label for risperiDONE for Extended-Release Injectable Suspension, 50 mg/vial, single-dose pack by Teva Pharmaceuticals, Inc. The kit contains a 50 mg vial of risperidone extended-release microspheres for injection, a single-dose pre-filled syringe with 2 mL diluent, a vial adapter, and safety needles for deltoid and gluteal intramuscular injection. The label includes storage instructions to keep the package refrigerated.*

FDA Label Image

1 (Image 6)

An instructional illustration showing a hand holding a small vial and using a dropper to extract liquid medication. This image likely demonstrates the proper technique for handling or preparing a dose from the vial included in the Risperidone human prescription drug kit by Teva Pharmaceuticals, Inc.*

FDA Label Image

1 (Image 7)

An instructional illustration showing a hand using a syringe, likely demonstrating the proper way to hold or operate the device. The image is simple line art with no visible text or additional context.*

FDA Label Image

1 (Image 8)

An instructional illustration showing two hands about to snap or break apart a small item, with the word 'SNAP!' and lines to emphasize the action. This image appears to be part of patient or product usage instructions.*

FDA Label Image

1 (Image 9)

Illustration demonstrating the preparation of a Risperidone injection kit by Teva Pharmaceuticals, showing a syringe being inserted and twisted onto a vial to withdraw medication, with arrows indicating twisting and downward motion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.